Differences in Services Provided at Public and Nonprofit Hospitals Related to the 340B Drug Discount Program

JAMA Health Forum Editor John Ayanian, MD, MPP, speaks with Kelsey M. Owsley, PhD, of the University of Arkansas, and Sayeh Nikay, PhD, MPH, of the University of Minnesota, about how the 340B drug discount program influences the services offered by public and nonprofit hospitals. They also discuss new state policies and proposed federal policies to promote greater transparency and accountability in the 340B program. Related Content: US Hospital Service Availability and New 340B Program Participation Public Hospitals May Use the 340B Program Differently Than Nonprofit Hospitals